ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid‐sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps

Background Locally advanced breast cancer (LABC) is still a common problem in developing countries. Extensive resections are aimed at local control and improving quality of life. Dermofat flaps are an option for medium‐sized defects. Objectives Evaluate the results of a new thoracoabdominal flap (TA...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2017-06, Vol.115 (8), p.949-958
Main Authors: Vieira, René Aloisio da Costa, da Silva, Katia Mathias Teixeira, de Oliveira‐Junior, Idam, de Lima, Marcos Alves
Format: Article
Language:English
Subjects:
Adult
Aged
Breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Cancer surgery
Female
Gangrene
Humans
locally advanced breast cancer
Mammaplasty
Mastectomy
Middle Aged
Multivariate analysis
Retrospective Studies
Surgical Flaps
Thoracic Wall - surgery
thoracoabdominal flaps
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Locally advanced breast cancer (LABC) is still a common problem in developing countries. Extensive resections are aimed at local control and improving quality of life. Dermofat flaps are an option for medium‐sized defects. Objectives Evaluate the results of a new thoracoabdominal flap (TAF). Methods We describe and evaluate an ipsilateral, thoracoabdominal horizontal, dermofat (ITADE) flap performed in patients submitted to mastectomy and immediate reconstruction. A systematic review of the flaps used in this situation was performed. Results A total of 23 patients underwent the ITADE flap. The average flap size was 360 cm2. One (4.3%) patient presented extensive loss of the flap. In the literature review, we observed 354 patients with 159 TAFs. We added our cases to the evaluation. A significant reduction in the risk of necrosis using myocutaneous flaps versus TAFs was observed (P 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.24619